Loading, please wait ...

News Analytics

20171226  27dcbaraw 1 jpg?w=654&h=434.
Boulder-based Array BioPharma (Nasdaq: ARRY) has spun out a new entity to research and develop drugs for rare diseases, according to documents filed with the U.S. Securities and Exchange Commission on Friday and first reported by finance news site Seeking Alpha. SEC filings show Array, which developed targeted drugs for cancer treatment, gave rights and assets from its ARRY-797 ...

The Angle

Subject Matter

  • Business, economics, society 74.65%
    • Companies, industries, organizations 62.26%
    • Society and people 37.74%
  • Healthcare 25.35%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction






Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.